Security key
89854M101
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)
CUSIP: 89854M101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Voting Common Stock, $0.0001 par value per share
- Shares outstanding
- 55,838,719
- Total 13F shares
- 41,522,755
- Share change
- -496,986
- Total reported value
- $126,231,784
- Price per share
- $3.04
- Number of holders
- 87
- Value change
- -$5,917,073
- Number of buys
- 41
- Number of sells
- 30
Report period
Q4 2024
Institutions
87
Top holders
10
TCRX full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
TScan Therapeutics, Inc. SEC filings
TScan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89854M101
Recent filing periods:
Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
|
Company |
9.4%
|
5,224,600
|
$26,018,508 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
9%
|
5,000,000
|
$24,900,000 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
4,632,876
|
$23,071,723 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
13D/G
|
Company · Adage Capital Management, L.P. |
7.1%
from 13D/G
|
4,400,000
|
$21,912,000 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
5.4%
|
2,989,474
|
$14,887,581 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5%
|
2,784,792
|
$13,868,264 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
2,346,894
|
$11,687,532 | — | 30 Sep 2024 | |
| Christoph H. Westphal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,193,472
|
$10,898,266 | — | 20 Jul 2021 | |
| Propel Bio Management, LLC |
13F
|
Company |
3.7%
|
2,087,139
|
$10,393,952 | — | 30 Sep 2024 | |
| Deer Management Co. LLC |
13F
|
Company |
2.2%
|
1,245,504
|
$6,202,610 | — | 30 Sep 2024 | |
| K2 HealthVentures Equity Trust LLC |
13D/G
|
— |
6.9%
|
3,602,700
|
$5,764,320 | $0 | 31 Dec 2024 | |
| Alphabet Inc. |
13F
|
Company |
1.9%
|
1,077,080
|
$5,363,858 | — | 30 Sep 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
1.9%
|
1,046,916
|
$5,213,642 | — | 30 Sep 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.8%
|
1,016,375
|
$5,061,548 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
973,466
|
$4,848,836 | — | 30 Sep 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.5%
|
860,951
|
$4,287,536 | — | 30 Sep 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
1.5%
|
825,341
|
$4,110,198 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
756,499
|
$3,767,365 | — | 30 Sep 2024 | |
| DC Funds, LP |
13F
|
Company |
1.1%
|
630,000
|
$3,137,400 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.67%
|
371,655
|
$1,850,842 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
324,276
|
$1,614,895 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.54%
|
299,319
|
$1,490,608 | — | 30 Sep 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.37%
|
205,730
|
$1,024,535 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.3%
|
165,160
|
$822,497 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
158,624
|
$789,948 | — | 30 Sep 2024 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0.26%
|
143,051
|
$712,394 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
134,297
|
$668,948 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
126,345
|
$629,198 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
112,941
|
$562,446 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.19%
|
108,584
|
$540,748 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.19%
|
103,440
|
$515,131 | — | 30 Sep 2024 | |
| Timothy J. Barberich |
3/4/5
|
Director |
—
mixed-class rows
|
135,286
mixed-class rows
|
$498,271 | — | 18 Dec 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.18%
|
99,133
|
$493,682 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
97,211
|
$484,111 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.17%
|
93,876
|
$467,502 | — | 30 Sep 2024 | |
| NewEdge Wealth, LLC |
13F
|
Company |
0.16%
|
91,463
|
$455,486 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
88,314
|
$439,804 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.15%
|
84,699
|
$421,801 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
74,000
|
$368,520 | — | 30 Sep 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.13%
|
71,800
|
$357,564 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
69,962
|
$348,411 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
58,067
|
$289,173 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.1%
|
55,845
|
$278,000 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.1%
|
54,564
|
$271,729 | — | 30 Sep 2024 | |
| Troluce Capital Advisors LLC |
13F
|
Company |
0.09%
|
52,914
|
$263,512 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
48,672
|
$242,387 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
47,203
|
$235,064 | — | 30 Sep 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
0.08%
|
43,723
|
$217,741 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
38,300
|
$190,734 | — | 30 Sep 2024 | |
| DC Investments Management, LLC |
13F
|
Company |
0.06%
|
35,563
|
$177,104 | — | 30 Sep 2024 |
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX) as of Q4 2024
As of 31 Dec 2024,
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,522,755 shares.
The largest 10 holders included
Lynx1 Capital Management LP, EcoR1 Capital, LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Propel Bio Management, LLC, Checkpoint Capital L.P., and Deer Management Co. LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
86
Q4 2024 holders
87
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.